brain/
← all entities
entityLINstock-market

Linde plc

Notes

Linde plc

One-line summary: Linde (NYSE: LIN) is the world's largest industrial gas company — the primary beneficiary of the Qatar helium supply shock, with 85-90% of helium book contracted and all helium upside excluded from guidance, making every incremental repricing at contract renewal pure EBITDA optionality.

What it is

Linde is the global leader in industrial, specialty, and atmospheric gases (oxygen, nitrogen, argon, hydrogen, helium, specialty gases). It serves semiconductor fabs, healthcare, energy, chemicals, and industrial markets. In the helium supply chain, Linde holds the most strategic position: its Beaumont, TX cavern (>85 million m³ capacity — approximately six months of global demand) and its large contracted book limit downside volatility while preserving upside through renewal pricing.

Valuation (September 22, 2026)

Last: $457.50 at the Monday 2026-09-21 4:00 PM ET NASDAQ close. From stockanalysis LIN ("457.50 −2.90 (−0.63%) At close: Sep 21, 2026, 4:00 PM EDT") and Alpaca daily bar 2026-09-21 close 457.5 (O 460.87 / H 461.43 / L 456.41 / C 457.5). NightDesk live ~$457.35 at clip is tape only — do not stamp as vault last.

Gage's judgment (as of 2026-09-22)

Gage via Leo, 22 Sep 2026 (Paul authorized). Small paper hold — Paul paper, 6.5 shares @ $457.83 (~3% sleeve). Range ~15% up / ~20% down over 6–12 months. Next gate: Q3 ~Oct 30 (issuer earnings date listed Oct 30, 2026 on stockanalysis LIN). Gage's judgment, not grain / not issuer fact. Last-price as-of stays the vault last: $457.50 (Monday 2026-09-21 4:00 PM ET). NightDesk live ~$457.35 at clip is tape only, not the vault last. Fill $457.83 is the paper entry, not a re-stamp of vault last. No source URL for the range — do not invent one. No BotBoard card. No new paper ticket from Leo.

Why it matters to stock-market

LIN is the cleanest large-cap indirect beneficiary of the Iran war/Ras Laffan helium shock. The mechanism: Qatar Ras Laffan (35% of global helium) is offline for 3-5 years; Linde's contracted book reprices at renewal into a structurally tighter market. J.P. Morgan upgraded to Overweight, PT $455→$525, citing LIN's historical ability to raise prices in inflationary supply environments. Every $100/Mcf increase in helium spot adds meaningful EBITDA — and guidance explicitly excludes helium upside, making the helium exposure pure optionality above the FY2026 EPS guide of $17.60-$17.90.

Key facts (Q1 2026 — primary source)

Key facts (Q2 2026 — reported 2026-07-31)

  • Record Q2 sales $9.3B (+9% YoY); EPS $4.50 (+10% YoY) — but shares fell ~5.2% on a margin disappointment (op margin ex-passthrough −30bp; reported 29.5%, −60bp). Per 2026-07-31-earnings-lin-q2-fy2026.
  • Electronics is the fastest-growing end market, +18%, on "hardware associated with AI" — sanjiv-lamba and CFO Matt White in 2026-07-31-earnings-lin-q2-fy2026. This is the picks-and-shovels leg: industrial gases gate advanced-node fabs. See picks-and-shovels-leading-edge-fab-buildout.
  • +$1B of new electronics backlog wins "to support the expansion of advanced node fabs invest in U.S." → record $8.1B sale-of-gas backlog (+$1B QoQ, expected to finish 2026 with an "eight handle"). sanjiv-lamba in 2026-07-31-earnings-lin-q2-fy2026.
  • Helium dislocation won't normalize until early 2027 — sanjiv-lamba in 2026-07-31-earnings-lin-q2-fy2026: "I don't think you will see normalization this year… it'll… probably take us into the early part of next year." The demand-side echo of the oil-supply shock: "countries highly dependent on hydrocarbons coming out of the Middle East have had to scale back industrial activity." Extends the helium-crunch clock (see helium-cliff-to-hbm-supply-crunch, helium-supply-crisis-semicap).
  • Margin drag = Lincare (US homecare) + helium dislocation. Lincare "headwind was larger than earlier estimates"; the company is "evaluating strategic options, including a possible partial or full divestiture." CFO Matt White sized the penalty ~30% above the analyst ~$100M/yr estimate; ex-Lincare, Americas margin would be +20bp. A Lincare divestiture would remove a low-margin homecare drag and re-focus LIN on its core gas franchise.
  • Guidance: Q3 2026 EPS $4.45–$4.55; FY2026 EPS $17.70–$17.90 (8–9% growth); H2: 20+ project startups (~$1.3B investment); price +2% broad-based.

CFO primary source claims

Strengths (from a thesis-input perspective)

  • Largest strategic helium cavern buffer — counterparty leverage at renewal
  • Guidance explicitly excludes helium upside → every incremental price move is a beat vs. consensus
  • Electronics segment tied to advanced node investment (LIN invests alongside fab construction)
  • J.P. Morgan coverage upgrade with $525 PT (8.5% upside from ~$483 pre-upgrade)

Weaknesses (from a thesis-input perspective)

  • 85-90% contracted = slow repricing; spot exposure is limited → helium windfalls accrue gradually at renewal
  • Woodside ATR/TNS systems slipped to Q1 2027 on Gulf Coast construction challenges
  • Geopolitical uncertainties kept FY2026 guidance ceiling unchanged despite floor raise

Related

Sources

Referenced by
Mechanisms
Qatar Ras Laffan halt → helium structural shortage → Linde contracted-book pricing power → LIN guidance optionalityQatar Ras Laffan helium halt → SK Hynix 6-month inventory cliff → HBM production constraint → Micron structural pricing premium
Questions
Is Air Products (APD) the under-followed second beneficiary of the Ras Laffan helium shortage?
Entities
Matthew White